Soleno Therapeutics, Inc. · NASDAQ:SLNO
FMR LLC reported a 11.20% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 6, 2026
FMR LLC reported a 11.20% stake in Soleno Therapeutics, Inc., 5,768,410 shares, as a passive investor on Mar 31, 2026. Filed May 6, 2026 (Schedule 13G/A).
- Stake
- 11.20%
- Shares
- 5,768,410
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 11.20% | 5,768,410 |
| Abigail P. Johnson | 11.20% | 5,768,410 |
Source
Related
- Soleno Therapeutics, Inc.
- FMR LLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · May 7, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2025
- Schedule 13G · FMR LLC · Aug 6, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026